Research Project

Project Title:	Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (VALIANT)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN) on the basis of a reduction in proteinuria.
Lead principal investigator(s):	. Multicenter, .
Co-investigator(s):	Erica Daina, Bergamo Gema Ariceta, Barcelona
Project Period:	05/2022 - 04/2024
Sponsors:	Industry
ClinicalTrials.gov:	NCT05067127